Concepedia

Habib Hamidi

HH

27

Publications

2.7K

Citations

22

H-Index

2002

Active since

Affiliations

University of California, Los Angeles(Current)

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Florida

Foundation Medicine (United States)

The University of Texas MD Anderson Cancer Center

Habib Hamidi is an author at University of California, Los Angeles specializing in medicine, oncology, and cell biology.

ORCID

Top concepts

Publications per year

2002–2025

27

Publications

27

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi et al. · Cancer Cell · 2020 · 520 citations · Full text

, , +8

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

Gottfried E. Konecny, Chen Wang, Habib Hamidi et al. · JNCI Journal of the National Cancer Institute · 2014 · 397 citations · Full text

, , +12

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

Jerry J. Jaboin, Jason R. Wild, Habib Hamidi et al. · PubMed · 2002 · 229 citations

, , +15

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 171 citations · Full text

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas Powles, Michael B. Atkins et al. · JAMA Oncology · 2021 · 155 citations · Full text

Rows per page

1–5 of 27